Moreover, the combination of the nano-vaccine with anti-PD-1 therapy exhibited outstanding efficacy in inhibiting tumor growth and metastasis in an in vivo mouse model, particularly in preventing tumor recurrence and promoting long-term survival. The gene discussed is PDCD1; the disease is neoplasm.